About the VHIR
Here at the Vall d'Hebron Research Institute (VHIR) we promote biomedical research, innovation and teaching. Over 1,800 people are seeking to understand diseases today so the treatment can be improved tomorrow.
Research
We are working to understand diseases, to find out how they operate and to create better treatments for patients. Get to know about our groups and their lines of research.
People
People are the centre of the Vall d'Hebron Research Institute (VHIR). This is why we are bound by the principles of freedom of research, gender equality and professional attitudes that HRS4R promotes.
Clinical trials
Our work is not just basic or translational; we are leaders in clinical research. Enter and find about the clinical trials we are conducting and why we are a world reference in this field.
Progress
Our aim is to make the research carried out at the Vall d’Hebron Research Institute (VHIR) a driving force for transformation. How? By identifying new channels and solutions for the promotion of people's health and well-being.
Core facilities
We offer specialist support for researchers, internal and external alike, ranging from specific services to preparing complete projects. All this, from a perspective of quality and speed of response.
News
We offer you a gateway for staying up to date on everything going on at the Vall d’Hebron Research Institute (VHIR), from the latest news to future solidarity activities and initiatives that we are organising.
Cardiovascular Diseases group is a translational research group within the Cardiology Department of Vall d’Hebron Hospital that performs laboratory, clinical and epidemiological research. In the CIBERCV network we are within the topic of descriptor 2 “Arterial disease, thrombosis and myocardial ischemia-reperfusion injury”. Our contributions in these topics address the following lines:
In the CIBERESP network, our group is interested in the study of effectiveness/cost-effectiveness of cardiovascular interventions, health outcome research and methods in clinical research. The group has 19 principal investigators, 32 active projects and clinical trial and has been done 142 publications in 2020.
PMID: 35260280 Journal: JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY Year: 2022 Reference: J Thorac Cardiovasc Surg. 2022 Feb 10. pii: S0022-5223(22)00131-3. doi: 10.1016/j.jtcvs.2022.02.007. Impact factor: 5.209 Publication type: Paper in international publication Authors: Bossone, Eduardo, Pai, Chih-Wen, Eagle, Kim, Sundt, Thoralf, Patel, Himanshu, Trimarchi, Santi, Eckstein, Hans-Henning, Schermerhorn, Marc, Estrera, Anthony, Chen, Edward P et al. DOI: 10.1016/j.jtcvs.2022.02.007
PMID: 35240010 Journal: NEW ENGLAND JOURNAL OF MEDICINE Year: 2022 Reference: N Engl J Med. 2022 Apr 28;386(17):1591-1602. doi: 10.1056/NEJMoa2200963. Epub 2022 Mar 4. Impact factor: 91.253 Publication type: Paper in international publication Authors: Rieckmann, Nina, Maurovich-Horvat, Pal, Bosserdt, Maria, Kofoed, Klaus F, Merkely, Bela, Knudsen, Andreas D, Benedek, Imre, Orr, Clare, Xavier Valente, Filipa, Zvaigzne, Ligita et al. DOI: 10.1056/NEJMoa2200963
PMID: 35233924 Journal: AGING CELL Year: 2022 Reference: Aging Cell. 2022 Mar;21(3):e13564. doi: 10.1111/acel.13564. Epub 2022 Mar 2. Impact factor: 9.304 Publication type: Paper in international publication Authors: Bou-Teen, Diana, Fernandez-Sanz, Celia, Miro-Casas, Elisabet, Nichtova, Zuzana, Bonzon-Kulichenko, Elena, Casos, Kelly, Inserte, Javier, Rodriguez-Sinovas, Antonio, Benito, Begona, Sheu, Shey-Shing et al. DOI: 10.1111/acel.13564
PMID: 35225793 Journal: EuroIntervention Year: 2022 Reference: EuroIntervention. 2022 Feb 28. pii: EIJ-D-21-00651. doi: 10.4244/EIJ-D-21-00651. Impact factor: 6.534 Publication type: Paper in international publication Authors: Sabate, Manel, Cuesta, Javier, Ortega-Paz, Luis, Brugaletta, Salvatore, Gomez-Lara, Josep, Alfonso, Fernando, Cequier, Angel, Romani, Sebastian, Bordes, Pascual, Serra, Antonio et al. DOI: 10.4244/EIJ-D-21-00651
PMID: 34012405 Journal: Frontiers in Physiology Year: 2021 Reference: Front Physiol. 2021 May 3;12:631326. doi: 10.3389/fphys.2021.631326. eCollection 2021. Impact factor: 4.566 Publication type: Paper in international publication Authors: Grignola, Juan C, Domingo, Enric, Lopez-Meseguer, Manuel, Trujillo, Pedro, Bravo, Carlos, Perez-Hoyos, Santiago, Roman, Antonio et al. DOI: 10.3389/fphys.2021.631326
PMID: 33362331 Journal: REVISTA ESPANOLA DE CARDIOLOGIA Year: 2021 Reference: Rev Esp Cardiol. 2021 Jun;74(6):558-559. doi: 10.1016/j.recesp.2020.12.004. Epub 2020 Dec 19. Impact factor: 4.753 Publication type: Letter whit IF Authors: Pons-Pellice, Laura, Camio-Visauta, Elena, Prat, Ivette Chocron-Da, Fernando Rodriguez-Palomares, Jose, Noguer, Ferran Roses, Nadal, Miriam De et al. DOI: 10.1016/j.recesp.2020.12.004
PMID: 33995537 Journal: ANALES DE PEDIATRIA Year: 2021 Reference: An Pediatr (Barc). 2021 Apr 20. pii: S1695-4033(21)00177-6. doi: 10.1016/j.anpedi.2021.04.009. Impact factor: 1.5 Publication type: Paper in national publication Authors: Esmel-Vilomara, Roger, Dolader, Paola, Sabate-Rotes, Anna, Soriano-Arandes, Antoni, Gran, Ferran, Roses-Noguer, Ferran et al. DOI: 10.1016/j.anpedi.2021.04.009
PMID: 34000021 Journal: Interactive cardiovascular and thoracic surgery Year: 2021 Reference: Interact Cardiovasc Thorac Surg. 2021 Oct 29;33(5):803-806. doi: 10.1093/icvts/ivab153. Impact factor: 0 Publication type: Paper in international publication Authors: Izquierdo-Blasco, Jaume, Riaza, Lucia, Pujol, Montse, Gran, Ferran, Fernandez-Doblas, Joaquin, Perez-Andreu, Joaquin, Abella, Raul F, Balcells, Joan et al. DOI: 10.1093/icvts/ivab153
PMID: 31049558 Journal: European Heart Journal-Cardiovascular Imaging Year: 2020 Reference: Eur Heart J Cardiovasc Imaging. 2020 Feb 1;21(2):210-221. doi: 10.1093/ehjci/jez078. Impact factor: 4.841 Publication type: Paper in international publication Authors: Romero-Farina, Guillermo, Candell-Riera, Jaume, Aguade-Bruix, Santiago, Garcia Dorado, David et al. DOI: 10.1093/ehjci/jez078
PMID: 31967733 Journal: JOURNAL OF CELLULAR AND MOLECULAR MEDICINE Year: 2020 Reference: J Cell Mol Med. 2020 Mar;24(5):2717-2729. doi: 10.1111/jcmm.14953. Epub 2020 Jan 22. Impact factor: 4.486 Publication type: Review in international publication Authors: Botker, Hans Erik, Cabrera-Fuentes, Hector Alejandro, Ruiz-Meana, Marisol, Heusch, Gerd, Ovize, Michel et al. DOI: 10.1111/jcmm.14953
PMID: 31954645 Journal: JACC-Cardiovascular Imaging Year: 2020 Reference: JACC Cardiovasc Imaging. 2020 Oct;13(10):2239-2244. doi: 10.1016/j.jcmg.2019.11.019. Epub 2020 Jan 15. Impact factor: 12.74 Publication type: Paper in international publication Authors: Cuellar-Calabria, Hug, Tornos, Pilar, Roque, Albert, Pizzi, Maria N, Fernandez-Hidalgo, Nuria, Gonzalez-Alujas, Maria Teresa, Rios, Remedios, Castell-Conesa, Joan, Escobar, Manuel, Ferreira-Gonzalez, Ignacio et al. DOI: 10.1016/j.jcmg.2019.11.019
PMID: 31932236 Journal: REVISTA ESPANOLA DE CARDIOLOGIA Year: 2020 Reference: Rev Esp Cardiol (Engl Ed). 2020 Jul;73(7):579. doi: 10.1016/j.rec.2019.10.021. Epub 2020 Jan 10. Impact factor: 4.642 Publication type: Paper in national publication Authors: Gonzalez Sucarrats, Silvia, Serra Garcia, Vicenc, Marti Aguasca, Gerard et al. DOI: 10.1016/j.rec.2019.10.021
The consensus document is the result of multidisciplinary work that takes into account the risks associated with all stages of women's lives and the differences compared to men.
The study, which involved Vall d'Hebron, developed an action plan to efficiently allocate resources to patients most at risk of suffering this complication.
In light of this evidence, hospitals such as Vall d'Hebron have already started to include warnings about environmental pollution in their hospital discharge plans after a myocardial infarction.
